Head to head for first-timers
CoreAge Rx vs KERNX Health
CoreAge Rx and KERNX Health both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #31 for first-timers · Grade C
Mama-Match
Best for: Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
Visit CoreAge RxKERNX Health
Rank #268 for first-timers · Grade C
Mama-Match
Best for: If you have already added the higher price to a consultation fee and it still works for your month.
Visit KERNX HealthThe verdict for a first step
CoreAge Rx edges out KERNX Health on the Mama-Match Score, 73 to 44 (C vs C). Someone comparing dose prices who can obtain the offer, state availability and order terms in writing.
KERNX Health is still a genuine option — credit where it is due: KERNX puts both numbers side by side, which almost nobody does. "From $129/mo · $249/mo after founding period" for semaglutide, "$199/mo · $299/mo" for tirzepatide. Nothing hidden. But look at what that candor reveals — the price nearly doubles on semaglutide once the founding window closes, and there is another cost in neither figure: consultation fees of $25 to $60, charged separately. So budget the higher number plus a consult fee. And the window that gets you $129 is called limited without ever saying how long it lasts. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | KERNX Health |
|---|---|---|
| Mama-Match Score | 73/100 · C | 44/100 · C |
| Overall rank | #31 | #268 |
| Semaglutide | $99/mo | $249/mo once the founding period ends |
| Tirzepatide | $149/mo | $299/mo once the founding period ends |
| Coverage | Therapy-specific state restrictions; confirm eligibility | Not stated on the site |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #31 · Grade C
What we like
- Published prices for both molecules, with the same advertised amount at each dose
- The offer includes medication, consultation and shipping, without an advertised membership fee
- The legal footer identifies the platform and the entities responsible for clinical care
The caveats
- The main site and a separate offer page show different prices
- The FAQ and policy differ on automatic rebilling and denial refunds
- State restrictions; orders become final when sent to pharmacy, with a 30-day refund cutoff
Mama-Match
KERNX Health
Rank #268 · Grade C
What we like
- Both prices sit together — no hunting for the real one
- It says consultation fees exist and gives the range instead of hiding them
- Cash-pay, so there is no insurance confusion
The caveats
- The price jumps when the founding period ends — $129 to $249 on semaglutide, nearly double, and $199 to $299 on tirzepatide
- Consultation fees of $25 to $60 sit on top of both figures
- It never says how long the founding period lasts
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and KERNX Health with the other providers we review for women.
Or browse the full comparison hub.